May Tech Global Investments, LLC Tempest Therapeutics, Inc. Transaction History
May Tech Global Investments, LLC
- $755 Million
- Q3 2024
A detailed history of May Tech Global Investments, LLC transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, May Tech Global Investments, LLC holds 10,000 shares of TPST stock, worth $7,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$7,100
Previous $21,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TPST
# of Institutions
34Shares Held
2.4MCall Options Held
44.9KPut Options Held
109K-
Black Rock Inc. New York, NY550KShares$390,6710.0% of portfolio
-
Altium Capital Management LP New York, NY545KShares$386,9500.27% of portfolio
-
Geode Capital Management, LLC Boston, MA220KShares$156,2470.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$125,0970.0% of portfolio
-
Fil LTD Hamilton, D0130KShares$92,0010.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $7.4M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...